Position in CELC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$55,545,059
+$2,546,662 QoQ
Shares Held
530,922
+14.3% QoQ
Ownership
1.09%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#24
of 274 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in CELC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ALLIANCEBERNSTEIN L.P. holds $5,177,674,273 across 256 Biotechnology names. CELC ranks #24 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,019,315 | $1,499,784,339 | |
| 2 | ARGX |
Argenx SE
|
395,661 | $367,082,405 | |
| 3 | GMAB |
Genmab A/S
|
8,644,877 | $237,474,771 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
292,338 | $182,284,436 | |
| 5 | TECH |
BIO-TECHNE Corp
|
2,002,026 | $141,443,136 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
1,696,538 | $132,788,029 | |
| 7 | KYMR |
Kymera Therapeutics, Inc.
|
981,521 | $112,551,013 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,453,504 | $108,256,977 |
All Filings in CELC
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $55,545,059 | 530,922 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $52,998,397 | 464,328 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $47,170,836 | 472,938 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $32,240,860 | 652,649 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $377,404 | 28,270 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $239,404 | 23,680 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $309,971 | 23,680 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $353,068 | 23,680 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $266,338 | 16,260 | Shares | Defined | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||